LLY

Eli Lilly & Co
D

LLY

740.31
USD
-17.85
(-2.35%)
Market Open
Volume
82,780
EPS
23
Div Yield
0.69
P/E
80
Market Cap
665,763,408,268
OverviewSignalsIdeasNews
Related Instruments
    AMGN
    AMGN
    1.21
    (0.45%)
    270.65 USD
    BMY
    BMY
    -0.035
    (-0.06%)
    56.365 USD
    GSK
    GSK
    -0.055
    (-0.16%)
    33.410 USD
    JNJ
    JNJ
    -0.550
    (-0.37%)
    147.270 USD
    MRK
    MRK
    -1.700
    (-1.69%)
    98.950 USD
    NVS
    NVS
    0.150
    (0.15%)
    97.970 USD
    PFE
    PFE
    -0.115
    (-0.43%)
    26.370 USD
    SNY
    SNY
    0.000
    (0.00%)
    50.625 USD
    More
News

Title: Eli Lilly & Co

Sector: Healthcare
Industry: Drug Manufacturers - General
Eli Lilly and Company researches, develops, manufactures, and sells pharmaceutical products for humans and animals. This American multinational pharmaceutical firm has its company headquarters in Indianapolis, Indiana. It also has branch locations in 18 countries around the world. Its products find their way into markets in roughly 125 countries globally. Some of the firm’s marquee pharmaceutical brands include the clinical depression drug Prozac and the antipsychotic medication Zyprexa. The company has been ranked in the top 150 firms of the Fortune 500 list of top American companies by revenue.
Trading. Social. Simple.
FacebookTwitterYoutube
Company
Contact usAbout usTerms Of UsePrivacy PolicyCookies PolicyDisclaimerHelp Center
Social Network
The NetworkSignals NetworkIdeas NetworkBest Traders
Products
Risk CalculatorPip CalculatorAdvance Chart
Markets
Exchange RatesCommodities RatesCryptocurrencies RatesIndices RatesUS Stocks Rates
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.